top of page
Monoclonal Antibodies Treatment

MONOCLONAL ANTIBODIES
TREATMENT FOR COVID-19

This treatment helps support your immune system to help fight Covid-19 infection.

_LC76276 copy-min.jpg

What are Monoclonal Antibodies?

Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful pathogens such as viruses, like SARS-CoV-2. 

 

And like other infectious organisms, SARS-CoV-2 can mutate over time, resulting in certain treatments not working against certain variants such as omicron. This is the case with these two treatments for which we’re making changes today.

What are the benefits?

This treatment can be helpful with assisting your immune system in overcoming the viral infection of Covid-19.

 

Monoclonal antibody therapy reduces deaths and hospitalizations in non-hospitalized patients with risk factors for severe disease progression.

​

The Monoclonal Antibody Treatment takes around 20-30 minutes. After treatment is administered, patients are monitored for one hour to ensure that they do not experience an allergic reaction or other adverse effect that requires medical attention. The whole process takes about 1-3 hours.

shutterstock_1656386548 copy-min.jpg

Who is eligible for this treatment?

People at high risk of severe disease progression from Covid-19. You’re eligible if you have at least one of the following:

shutterstock_1296377218 copy-min_edited.jpg

Body Mass Index of 30+ in adults, or 85%+ in children ages 12-17.

Body Mass Index of 30+ in adults, or 85%+ in children ages 12-17.

shutterstock_1921373294 copy-min.jpg

Chronic kidney disease, diabetes, or a medication or condition.

Chronic kidney disease, diabetes, or a medication or condition.

shutterstock_1921039325 copy-min.jpg

Being 65+ years old

This age group has a  80 times higher death rate from Covid-19 than those aged 18-29.

Being 65+ years old

This age group has a  80 times higher death rate from Covid-19 than those aged 18-29.

shutterstock_2066841269 copy-min.jpg

Being 55+ years with a chronic respiratory, cardiovascular disease, or hypertension.

Being 55+ years with a chronic respiratory, cardiovascular disease, or hypertension.

shutterstock_1827358853 copy-min.jpg

Pregnancy

Pregnancy

shutterstock_2114670407 copy-min_edited.jpg

Being 12-17 yrs old 

with Sickle Cell Disease, chronic respiratory disease, neurodevelopmental disorder, asthma, or medical-related technological dependence.

Being 12-17 years old 

with Sickle Cell Disease, chronic respiratory disease, neurodevelopmental disorder, asthma, or medical-related technological dependence.

You are NOT eligible for this treatment if you are currently hospitalized for Covid-19, severely ill or requiring oxygen therapy due to Covid-19, allergic to any of the ingredients in the treatment, not showing any symptoms of Covid-19 or outside of the 10-day window since the start of symptoms and positive test result.

_LC74114-min_edited.jpg
  • What can I expect from treatment?
    The Monoclonal Antibodies Treatment is administered at our infusion center and is given through IV Infusion. The whole process takes about 1-3 hours.
  • Can monoclonal antibody treatment make me sick?
    Antibody treatments do not contain any live virus, so there is no risk you will get COVID-19 from mAb treatment. However, the antibody treatment may have side effects like: Allergic reactions, brief pain, bleeding, bruising of the skin, soreness, swelling.
  • Who is this treatment for?
    This treatment is helpful to people with a high risk of severe disease progression from Covid-19.
  • What if I do not qualify for monoclonal antibody treatment?
    We may decide you do not qualify for the Monoclonal Antibodies Treatment for several reasons. If you have any questions or want to find alternative solutions we recommend contacting our facility or request an appointment.

Frequently Asked Questions (FAQ)

bottom of page